Our team has global network. We understand the healthcare market and your pressing needs.
Area of expertise：management, strategy, lifescience, health technologies,start-up, Japanese, cross-cultural business liaisons
Chika has consulted number of major global corporations for their business/market strategies in the area of healthcare.
Background: Before founding Gallasus, Chika worked at AGY Therapeutics, Inc., biotech company, one of founding members and served as Director of Business Development. Chika also worked at Lynx Therapeutics, acquired by Illumina, and Neurex Corporation,acquired by Elan Pharmaceuticals. Earlier in her career she held a position at the Research Division of Snow Brand Milk Products Co. Ltd, in Japan. Chika received her BE in Industrial Chemistry from Chuo University in Japan.
Diether J. Recktenwald, PhD Senior adviser
Area of expertise：R&D management、technology evaluation, lifescience, imaging technologies
Diether has developed and managed numerous products in the area of imaging, cell analysis and stem cell through his career. Diether was responsible for the identification, and evaluation of novel technologies at BD Biosciences.
Background: Formerly Vice President of Advanced Technology, Becton, Dickinson and Company and BD fellow emeritusPh.D., Biology, University Bochum, Postdoc Stanford University, Struct. Biology and Biophysics
Area of expertise：management, strategy, marketing, sales, medical device, healthcare technologies, Japanese
Geoff has extensive hands on management experience in the Western, Japanese and Asia-Pacific healthcare industry including serving as President and Representative Director of a $100 Mil. medical device company in Japan and as leader of a sales and rental service force of over 400 people.
Background：Formerly President (Japan) for Abbott Vascular, Marketing Director for the Cordis Cardiology Div. of Johnson & Johnson
Bachelor Economics, with Japanese Studies at University of Western Australia, MBA at Stanford Graduate School of Business
Area of expertise：health/clinical technologies, lifescience, start-ups, technology evaluation, strategy
David is an expert in new health technologies, which has led him to be involved in new technology development, science policy serving on a number of committees, co-authoring a number of publications, and lobbying activities related to science research.
Background：Formerly Global Head, Human Health Solutions at Pfizer, Senior Science Advisor for CDER at FDA
David received his Ph.D. from Northwestern University and held academic appointments at NIH, Harvard Med School, and the Weizmann Institute.
© Gallasus All rights reserved.